Aimmune Therapeutics Receives EMA Decision Agreeing With PIP for AR101 for the Treatment of Peanut Allergy by longitudeadmin | Oct 7, 2015 | Portfolio News
Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease by longitudeadmin | Sep 30, 2015 | Portfolio News
CardioDx Announces Positive Data from a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women by longitudeadmin | Sep 30, 2015 | Portfolio News
